Answers are grounded in this paper and cite their sources.
Introduction Anastomotic leakage remains one of the most serious complications following gastrointestinal surgery and is associated with substantial morbidity and mortality. Although tissue adhesives have been proposed to reinforce intestinal anastomoses, their preclinical evaluation still relies largely on animal models with limited translational relevance and ethical concerns. This study aimed to evaluate a six-armed star-shaped polyethylene oxide-stat-propylene oxide tissue adhesive (sPEG) using a comprehensive 3R-compliant bioevaluation platform combining standardized in vitro testing with a dynamic ex vivo porcine intestinal perfusion model. Methods The cytocompatibility and hemocompatibility of sPEG were assessed according to DIN EN ISO 10993 using human dermal fibroblasts and human blood-derived assays. Performance was benchmarked against the clinically established tissue adhesives DERMABOND™ and TISSEEL TM . Sealing efficacy was evaluated in a custom-developed ex vivo porcine small-intestine perfusion model employing intestinal segments ≥15 cm exposed to continuous intraluminal flow for 24 h under physiologically relevant conditions. Leakage volume, time to first leakage, and drop rate were recorded. Results DERMABOND TM extracts induced significant cytotoxicity, whereas TISSEEL TM and sPEG showed no relevant cytotoxic effects. All three materials exhibited negligible hemolysis. Thrombocyte adhesion was minimal on sPEG, intermediate on DERMABOND TM , and pronounced on TISSEEL TM . In the ex vivo perfusion model, sPEG prevented detectable leakage throughout the entire 24 h observation period and demonstrated a drop rate of 0 drops/h. DERMABOND TM and TISSEEL TM exhibited leakage during perfusion, with TISSEEL TM showing the weakest sealing performance. DERMABOND TM provided relatively good mechanical sealing but was associated with marked cytotoxicity. Overall, sPEG combined effective sealing performance with excellent biological compatibility. Discussion The presented platform enables physiologically relevant and ethically responsible preclinical assessment of intestinal tissue adhesives by integrating standardized biocompatibility testing with continuous-flow ex vivo perfusion. Within this framework, the six-armed sPEG adhesive demonstrated a favorable combination of cytocompatibility, hemocompatibility, and sealing efficacy superior to the clinically used comparators. These findings identify sPEG as a promising candidate for further translational development and establish the presented ex vivo model as a versatile 3R-compliant screening platform for next-generation intestinal sealants.
No takes yet. Share an insight, caveat, or question.
Gruhn et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: